L’avis intitulé « Vaccin antigrippal FLUCELVAX : transition du vaccin antigrippal FLUCELVAX, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
dB1QMY9E4qtYrh3v
